Medical robotics is a rapidly growing area in the medical devices industry, the surgical robotics segment being at the top of the market. According to GlobalData forecasts, the total surgical robotics market will have experienced strong annual growth (TCAC) of 8.5 % between 2020 and 2030, supported by the upcoming marriage of artificial intelligence (AI) and robotics within medical devices.
The surgical robotics market can be segmented into equipment and consumable accessories. The accessories of robotic surgical systems occupy the majority of the market, stimulated by the requirements of large volume procedures. Depending on the types of procedures, the surgical robotics market can be divided into three main sub-segments: general surgery robotics, orthopedic robotics and neurosurgery robotics. The number of surgical interventions carried out using surgical robots should grow at a 10.5 % TCAC in the United States between 2020 and 2030. The COVVI-19 had a negative impact on the number of robotic surgical interventions Due to the cancellation of elective surgical interventions in the second quarter. However, from 2020 to 2022, the negative impact of the COVVI-19 on robotic surgery was offset by organic growth.
However, not all businesses are concerned with regard to their capacity and investments in the most important key themes for their sector. Understanding how companies are positioned and classified in the most important themes can be a key indicator of their potential for future benefits and their relative competitive position.
According to the thematic research report of GlobalData, Robotics in medical devicesThe main users include: Intuitive Surgical, Medtronic,, CyberdyneGlobus, Hollyys, IrobotJohnson & Johnson, OmronREWALK ROBOTICE AND Stryker.
Points of view of several of the best classified companies
Johnson & Johnson
Johnson & Johnson announced the details of his new robotic surgical system, Ottava, in 2020 after acquiring Auris Health and his monarch system for bronchoscopic procedures in 2019. Throughout 2021, Johnson & Johnson worked for validation of the system system Ottava and planned to start clinical trials in 2022. The company indicated that Ottava will be able to carry out various procedures that overlap the Da Vinci system. Business unit Synths Depuy announced that it has received the FDA 510 (K) authorization for the VELYS system in 2021. The system should be integrated into large and compact operating rooms, adapting to the surgeon’s workflow and helping to run cuts precise bones for total knee arthroplasty procedures.
Stryker is a leader in the field of implant implants and procedures for hip and knee arthroplasties. The number of people requiring arthroplasty of the knee and hip increases rapidly and will not slow down in the predictable future, in particular with the rapid urbanization of China, India and Africa. In 2018, Stryker A acquired K2M, a leader in the field of complex solutions for the spine and mini-invasive, for $ 1.4 billion. According to StrykerThis operation completes its leadership on the markets of the spine and neurotechnologies. Stryker Developed Mako, a robotic arm that assists the surgeons during interventions. COVVI-19 has had an impact on business activities, as elective procedures have been reported so that health systems around the world can focus on the treatment of patients infected with the virus. However, Stryker The situation bounces with the return of elective procedures in countries that have managed to control the pandemic thanks to the vaccines.
Omron Factory of large -scale electronic components and systems for industrial automation and health care. As Mastence And Nabtesco,, Omron is a key supplier of the robotics industry. It should benefit from China’s desire to automate its manufacturing base, because it is a major initiative for the country in recent years. The company has diversified with an autonomous intelligent vehicle (AIV) to move goods and materials in factories and warehouses. Its main launch in 2021 took place in the health field. Omron has developed its first electrocardiogram and unique derivation blood pressure monitoring for domestic use.
To better understand the key themes and technologies that disrupt the medical industry, access the latest thematic research report of GlobalData on Robotics in medical devices.
- Abbott
- Philips
- Apple
- Rock
- Hill
- Dexcom
- Alphabet
- Quest diagnosis
- Agilent technology
- QIIAGEN
- 3m
- Nihon Kohden
- Danaher
- Becton Dickinson
- Illuminated
- Television
- Garmin
- Smith and Neveu
- Thermo Fisher Scientific
- Biotronik
- Swing
- EDWARDS Life Sciences
- Coloplast
- Terumo
- Microport
From
The reference in business intelligence.
Combining expert knowledge and cutting -edge technology, the unequaled exclusive data from GlobalData will allow you to decode what is happening on your market. You can make more informed decisions and benefit from a lasting advantage over your competitors.
Frequently asked questions
-
1. How do medical devices use robotics?
Medical devices companies use robotics to improve the quality of care and help humans perform tasks that they might not have accomplished. The two main types of medical robots are surgical robots and treatment robots. Other types of robots could be used in a medical context, including exoskeletons. Cleaning and maintenance robots are used in hospitals and retirement homes, but are not explicitly designed for medical use.
-
2. What is the impact of robotics on the medical devices industry?
Robotics have a significant impact on the medical devices industry. Using Cloud Computing and AI allows robots to collaborate and access huge amounts of data without interruption. Automation is essential to improve productivity. As countries and businesses recover from the pandemic, the interest in robotics will increase. Robust growth is expected in the field of medical robotics over the next decade.
-
3. Who are the main users of robotics in the field of medical devices?
The main users of robotics in the field of medical devices are intuitive Surgical, Medtronic, Johnson & Johnson, Stryker, Zimmer Biomet and Cyberdyne. These companies pave the way to the development and adoption of surgical robots and care robots.
-
4. Who are the main robotics suppliers in the medical devices industry?
The main robotics suppliers in the medical devices sector include ABB, Cognex, Microsoft, Rockwell Automation, Google, Amazon, Amazon, Preferred Networks, Fanuc, C2ro, MIDEA (KUKA) and Cisco.
-
5. How does robotics investment help companies with medical devices?
Investment in robotics can lead to improved productivity and efficiency, as well as better results for patients.
-
6. What are the challenges linked to the adoption of robotics in medical devices?
The challenges linked to the adoption of robotics in catering include high initial costs, the lack of skilled labor to operate and maintain robots, as well as concerns about the impact on employment. There are also regulatory challenges.
-
7. What is the projected size of the robotics market in medical devices?
According to GlobalData forecasts, the total surgical robotics market will have experienced strong annual growth (TCAC) of 8.5 % between 2020 and 2030, supported by the upcoming marriage of artificial intelligence (AI) and robotics within medical devices.
-
8. Who are the main providers of robotics specializing in medical devices?
The main providers of robotics specializing in medical devices include Harmonic Drive, Omron, Te Connectivity, Nabtesco, Keyence and Honeywell. These companies provide precision mechanical parts and semiconductors which are essential components of medical robots.
-
9. What are the components of the robotics value chain?
The components of the robotics value chain include the manufacturing of robots, the material components (such as precision mechanical parts and semiconductors), software components (such as robotic intelligence and cloud robotics) and robotics as a service.